Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Jazz Pharmaceuticals plc (JAZZ)

$205.06 -0.83% NASDAQ: JAZZ · 15-min delayed
  • DUBLIN,
  • Public · NASDAQ: JAZZ
  • 2,890 employees
$15.9BMarket cap
$4.3BRevenue · FY2025
-$356.1MNet income
2,890Employees
JAZZNASDAQ
2007IPO

About Jazz Pharmaceuticals plc

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$4.3B
Net income
-$356.1M
Total assets
$11.7B
Market cap
$15.9B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: JAZZ
$205.06 -0.83%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$127.00 $261.62

52-week range

Market cap
$15.9B
Shares outstanding
77.8M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Jun 1, 2007

Jazz Pharmaceuticals plc (JAZZ) Stock Price

  • Reported a net loss of $356.1M in FY2025.
  • Trading 22% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Jazz Pharmaceuticals plc.

Write a review
Newsroom

News about Jazz Pharmaceuticals plc

News & sentiment via Polygon.io

FAQ

Jazz Pharmaceuticals plc: frequently asked questions

Is Jazz Pharmaceuticals plc an American company?

Jazz Pharmaceuticals plc is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Jazz Pharmaceuticals plc publicly traded?

Yes — Jazz Pharmaceuticals plc is a publicly traded company. Its stock trades under the ticker symbol JAZZ on the NASDAQ.

What does Jazz Pharmaceuticals plc do?

Jazz Pharmaceuticals plc is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →